<code id='A992BB337E'></code><style id='A992BB337E'></style>
    • <acronym id='A992BB337E'></acronym>
      <center id='A992BB337E'><center id='A992BB337E'><tfoot id='A992BB337E'></tfoot></center><abbr id='A992BB337E'><dir id='A992BB337E'><tfoot id='A992BB337E'></tfoot><noframes id='A992BB337E'>

    • <optgroup id='A992BB337E'><strike id='A992BB337E'><sup id='A992BB337E'></sup></strike><code id='A992BB337E'></code></optgroup>
        1. <b id='A992BB337E'><label id='A992BB337E'><select id='A992BB337E'><dt id='A992BB337E'><span id='A992BB337E'></span></dt></select></label></b><u id='A992BB337E'></u>
          <i id='A992BB337E'><strike id='A992BB337E'><tt id='A992BB337E'><pre id='A992BB337E'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          knowledge

          author:explore    - browse:28

          When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin. We also discuss the latest news in the life sciences, including the future of Sarepta and the retirement of a biotech stalwart.

          advertisement

          For more on what we cover, here’s where you can read Frank’s work; here’s more on Sarepta; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          leisure time